B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

The contributions of the humoral immune response to melanoma are now widely recognized, with reports of positive prognostic value ascribed to tumor-infiltrating B cells (TIL-B) and increasing evidence of B cells as key predictors of patient response to treatment. There are disparate views as to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Willsmore, Zena N., Harris, Robert J., Crescioli, Silvia, Hussein, Khuluud, Kakkassery, Helen, Thapa, Deepika, Cheung, Anthony, Chauhan, Jitesh, Bax, Heather J., Chenoweth, Alicia, Laddach, Roman, Osborn, Gabriel, McCraw, Alexa, Hoffmann, Ricarda M., Nakamura, Mano, Geh, Jenny L., MacKenzie-Ross, Alastair, Healy, Ciaran, Tsoka, Sophia, Spicer, James F., Papa, Sophie, Barber, Linda, Lacy, Katie E., Karagiannis, Sophia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868381/
https://www.ncbi.nlm.nih.gov/pubmed/33569063
http://dx.doi.org/10.3389/fimmu.2020.622442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868381/
https://www.ncbi.nlm.nih.gov/pubmed/33569063
http://dx.doi.org/10.3389/fimmu.2020.622442

Ejemplares similares